Evidence map›Paper›PMID 36769059›Full record

ReviewInternational journal of molecular sciences2023

Tryptophan and Substance Abuse: Mechanisms and Impact.

Majid Davidson, Niloufar Rashidi, Md Kamal Hossain, Ali Raza, Kulmira Nurgali, Vasso Apostolopoulos

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Analysis of the underlying mechanism ofPharmaceutical science advances · 2024
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Majid DavidsonInstitute for Health and Sport, Victoria University, Melbourne, VIC 3021, Australia.ORCID 0000-0002-3241-6444
Niloufar RashidiInstitute for Health and Sport, Victoria University, Melbourne, VIC 3021, Australia.
Md Kamal HossainInstitute for Health and Sport, Victoria University, Melbourne, VIC 3021, Australia.
Ali RazaFiona Elsey Cancer Research Institute, Ballarat, VIC 3353, Australia.
Kulmira NurgaliInstitute for Health and Sport, Victoria University, Melbourne, VIC 3021, Australia.ORCID 0000-0002-2597-6929
Vasso ApostolopoulosInstitute for Health and Sport, Victoria University, Melbourne, VIC 3021, Australia.ORCID 0000-0001-6788-2771

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Addiction, the continuous misuse of addictive material, causes long-term dysfunction in the neurological system. It substantially affects the control strength of reward, memory, and motivation. Addictive substances (alcohol, marijuana, caffeine, heroin, methamphetamine (METH), and nicotine) are highly active central nervous stimulants. Addiction leads to severe health issues, including cardiovascular diseases, serious infections, and pulmonary/dental diseases. Drug dependence may result in unfavorable cognitive impairments that can continue during abstinence and negatively influence recovery performance. Although addiction is a critical global health challenge with numerous consequences and complications, currently, there are no efficient options for treating drug addiction, particularly METH. Currently, novel treatment approaches such as psychological contingency management, cognitive behavioral therapy, and motivational enhancement strategies are of great interest. Herein, we evaluate the devastating impacts of different addictive substances/drugs on users' mental health and the role of tryptophan in alleviating unfavorable side effects. The tryptophan metabolites in the mammalian brain and their potential to treat compulsive abuse of addictive substances are investigated by assessing the functional effects of addictive substances on tryptophan. Future perspectives on developing promising modalities to treat addiction and the role of tryptophan and its metabolites to alleviate drug dependency are discussed.

Indexed as

Behavior, AddictiveCentral Nervous System StimulantsMethamphetamineSubstance-Related DisordersAnimalsBrainHumansMammalsTryptophanCentral Nervous System StimulantsMethamphetamineTryptophanaddictionkynureninemental healthmethamphetamineserotonintryptophan

Identifiers

PMID36769059
PMCPMC9917371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.